共 50 条
- [1] Pioglitazone (PIO) improves atherogenic dyslipidemia in drug-therapy naive patients with type 2 diabetes (T2DM)[J]. DIABETES, 2002, 51 : A497 - A497Tan, MHHerz, MJohns, DRobertson, KEGonzalez, BReviriego, JGrossman, LD
- [2] Pioglitazone (PIO) enhances insulin sensitivity (IS) in patients with type 2 diabetes (T2DM)[J]. DIABETES, 2002, 51 : A102 - A102Johns, DHerz, MTan, MHRobertson, KEGonzalez, BReviriego, JGrossman, LD
- [3] Empagliflozin as Add-On to Pioglitazone With or Without Metformin Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A291 - A291Kovacs, ChristopherSeshiah, VeeraswamySwallow, RosJones, RussellRattunde, HenningWoerle, Hans J.Broedl, Uli C.
- [4] Empagliflozin Monotherapy Improves Glucose Control in Drug-Naive Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A280 - A280Roden, MichaelWeng, JianpingEilbracht, JensDelafont, BrunoKim, GabrielWoerle, Hans J.Broedl, Uli C.
- [5] Colesevelam HCl improves glycemic control in patients with type 2 diabetes (T2DM): A pilot study[J]. DIABETES, 2006, 55 : A134 - A134Schwartz, Sherwyn L.Zieve, FranklinKalin, MarciaJones, Michael R.
- [6] Empagliflozin Monotherapy for 12 Weeks Improves Glycemic Control in Japanese Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A297 - A298Kadowaki, TakashiHaneda, MasakazuInagaki, NobuyaTaniguchi, AtsushiSakamoto, MasashiKoiwai, KazukiRattunde, HenningWoerle, Hans J.Broedl, Uli C.
- [7] Effects of Extended Pioglitazone Treatment (PIO) on Bone Metabolism in Patients with Prediabetes and Type 2 Diabetes Mellitus (T2DM)[J]. DIABETES, 2014, 63 : A293 - A294Sanchez, Paola PortilloBril, FernandoLomonaco, RominaMaximos, MaryannBruder, JanOrsak, BeverlyHecht, JoanCusi, Kenneth
- [8] Colesevelarn HCI improves glycemic control in type 2 diabetes mellitus (T2DM) subjects managed with insulin therapy[J]. CIRCULATION, 2006, 114 (18) : 306 - 306Goldberg, Ronald B.Truitt, Kenneth
- [9] Empagliflozin as Add-On to Metformin for 24 Weeks Improves Glycemic Control in Patients With Type 2 Diabetes (T2DM)[J]. DIABETES, 2013, 62 : A282 - A282Haering, Hans-UlrichMerker, LudwigSeewaldt-Becker, ElkeWeimer, MarcMeinicke, ThomasBroedl, Uli C.Woerle, Hans J.
- [10] Sitagliptin added to ongoing treatment with pioglitazone improved glycemic control and was well tolerated in Japanese patients with type 2 diabetes (T2DM)[J]. DIABETES, 2008, 57 : A590 - A590Kashiwagi, AtsunoriTajima, NaokoKadowaki, TakashiNonaka, KenjiMoto, TarookaOkuyama, KotobaNishii, MikioStein, Peter R.